Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07248956 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 30, 2025 to Dec 22, 2025
    • Site details revised at 7 of 7 sites
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multi-center, randomized controlled, prospective clinical study.
Trial Details
NCT Number NCT07248956
Lead Sponsor Eye & ENT Hospital of Fudan University
Conditions
(from sponsor)
Hypopharyngeal Carcinoma
Related terms Hypopharyngeal Neoplasms
Enrollment 116 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov